CLINICAL_TRIALS
trial_result
· 2011-11-23
Clinical Trial Update: Treatment of Chronic Immune Thrombocytopenic Purpura (ITP) With Intravenous Immunoglobulin IgPro10 [Phase 3]
Summary
A Phase 3 trial evaluating Intravenous Immunoglobulin IgPro10 for immune thrombocytopenia has completed, with results posted in 2011.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: CSL Behring | Conditions: Immune Thrombocytopenic Purpura | Phase 3 | Status: COMPLETED | Results posted: 2011-11-23